Receptor-mediated endocytosis of extracellular angiotensin II (Ang II) has been suggested to play an important role in the regulation of proximal tubule cell (PTC) function. Using immortalized rabbit PTCs as an in vitro cell culture model, we tested the hypothesis that extracellular Ang II is taken up by PTCs through AT 1 (or AT 1a ) receptormediated endocytosis and that inhibition of Ang II endocytosis using a selective AT 1 receptor siRNA (AT 1 R siRNA) or endocytotic inhibitors exerts a physiological effect on total and apical NHE-3 protein abundance. Western blots and live cell imaging with FITC-labeled Ang II confirmed that transfection of PTCs with a human-specific AT 1 R siRNA (AT 1 R siRNA) for 48 h selectively knocked down AT 1 receptor protein by 76 ± 5% (p < 0.01), whereas transfection with a scrambled siRNA had little effect. In nontransfected PTCs, exposure to extracellular Ang II (1 nM) for 60 min at 37°C increased intracellular Ang II accumulation by 67% (control: 566 ± 55 pg/mg protein vs. Ang II: 943 ± 160 pg/mg protein, p < 0.05), and induced mitogen-activated protein kinase ERK1/2 phosphorylation (163 ± 15% of control, p < 0.01). AT 1 R siRNA reduced Ang II endocytosis to a level similar to losartan, which blocks cell surface AT 1 receptors (557 ± 37 pg/mg protein, p < 0.05 vs. Ang II), or to colchicine, which disrupts cytoskeleton microtubules (613 ± 12 pg/mg protein, p < 0.05 vs. Ang II). AT 1 R siRNA, losartan, and colchicine all attenuated Ang II-induced ERK1/2 activation and total cell lysate and apical membrane NHE-3 abundance. The scrambled siRNA had no effect on Ang II endocytosis, ERK1/2 activation or NHE-3 expression. These results suggest that AT 1 receptor-mediated endocytosis of extracellular Ang II may regulate proximal tubule sodium transport by increasing total and apical NHE-3 proteins.
Introduction
Angiotensin II (Ang II) is well recognized as one of the most powerful vasoactive peptides in the regulation of body salt and fluid balance and blood pressure homeostasis in health as well as in disease (23, 28, 37, 55) . Ang II is produced and exerts its biological and physiological effects in three different manners. First, it is formed in the circulation via actions of kidney-derived renin and vascular ACE and acts as an endocrine hormone to regulate blood pressure (20,7). Second, Ang II may be synthesized inside the cells of many target tissues including the kidney, heart and brain, and upon release it alters the function of adjacent cells in a paracrine manner (7, 12, 16, 29) . Third, it is increasingly realized that Ang II can enter the cells via receptormediated endocytosis or is synthesized intracellularly, where it may act as an intracrine peptide (18, 34, 40, 49, 53, 56) . Although the endocrine and paracrine effects of Ang II have been studied extensively in different target tissues, the roles of intracellular Ang II remain poorly understood. The proximal tubule of the kidney is an exemplary target of PTCs, cells grown on coverslips were first incubated with losartan (10 µM) for 30 min before imaging with FITC-labeled Ang II. Experiments were also performed using non-transfected PTCs which were treated with cold, colchicine or PAO for comparison with AT 1 R siRNA as described (34) . After incubation, the medium was removed and cells washed with ice-cold acid buffer to remove membrane-bound agonist before extraction of protein samples for ELISA of Ang II as described previously (34, (54) (55) (56) .
Effects of AT

Effects of blockade of Ang II endocytosis by AT 1 R siRNA, losartan and other endocytotic inhibitors on MAP kinase ERK 1/2 activation and NHE-3 expression
To determine whether AT 1 receptor-mediated endocytosis of extracellular Ang II is involved in regulating proximal tubule sodium transport, total and phosphorylated ERK 1/2 (33) (34) (35) 54, 56 ) and lysate and cell surface NHE-3 proteins were evaluated by Western blot as described (1, 5, 31, 32) . Non-transfected and AT 1 R siRNA-transfected PTCs were sub-cultured to 60-80% confluence in 6-well plates before being treated with vehicle (serum-free medium), Ang II (1 nM), Ang II plus losartan (10 MM), Ang II plus the cytoskeleton microtubule inhibitor, colchicine (1 MM) (17, 34, 43) , or Ang II plus the tyrosine phosphatase inhibitor, PAO (1 MM) for 60 min at 37°C (22, 34, 44) . In separate experiments, PTCs were incubated with Ang II for 60 min at 4°C to inhibit AT 1 receptor endocytosis for comparisons. After treatment, the cells were washed and protein samples extracted for measurement of total and phosphorylated ERK 1/2 as described (33) (34) (35) as well as total and surface NHE-3 proteins by Western blot (1, 5, 31, 32) . To measure cell surface NHE-3 protein, standard cell-surface biotinylation procedures were followed to obtain cell surface proteins for Western blot as described previously (1, 5, 32) . Briefly, sub-confluent PTCs were transfected with AT 1 R siRNA or scrambled RNA or treated with losartan or colchicine, as described above. After treatment, PTCs were washed twice with ice-cold phosphate-buffered saline (PBS) and cell surface proteins biotinylated by incubating the cells with buffer containing 1.5 mg/ml sulfo-NHS-SS-biotin, 10 mM triethanolamine (pH 7.4), 2 mM CaCl 2 and 150 mM NaCl for ~ 2 h at 4°C (5). The cells were washed with quenching buffer (PBS containing 1 mM MgCl 2 , 0.1 mM CaCl 2 , and 100 mM glycine) for 20 min to clear unbound biotin. PTCs were lysed with a modified RIPA buffer (50 mM Tris-HCl, 50 mM, 1% NP-40, 0.25% Nadeoxycholate, 150 mM NaCl, 1 mM EDTA, 1 mM PMSF, 1 Mg/ml each of aprotinin, leupeptin, and pepstatin, 1 mM Na 3 VO4, and 1 mM NaF, pH 7.4), centrifuged, and lysates collected. The samples were incubated with avidin-agarose beads (Pierce) (1, 5, 32) .
Western blots of AT 1 receptor proteins, NHE-3, -actin, and total and phosphorylated ERK 1/2
For Western blots of protein abundance, PTCs were washed twice with ice-cold PBS after treatment and lysed with a modified RIPA buffer as described above. Protein samples were extracted and concentrations determined using a BCA protein assay kit (Pierce) and Prism 4.0. PTC protein samples (10 Mg each) were electrophoretically separated on 8-16% Tris-glycine gels at 120 V for 1.5 to 2 h. After SDS separation, proteins were transferred to Millipore Immobilon-P membranes using a Bio-Rad TransBlot Semi-Dry system powered by a Bio-Rad Power-Pac HC (25V, 0.12A, 1.5 h). The membranes were blotted overnight at 4°C with 5% non-fat dry milk and incubated for 3 h at room temperature with a rabbit polyclonal antibody against the human AT 1 receptor (1:200) (Santa Cruz) (34, 54, 56) . The specificity of this antibody has been verified previously (34, 54, 56) . Total and cell surface NHE-3 proteins were detected using a goat polyclonal NHE-3 antibody targeting the C-terminus of human origin of NHE-3 (Santa Cruz). Specificity of the NHE-3 antibody was verified using a selective NHE-3 antigen blocking peptide, SC-10163P (Santa Cruz). Total and phosphorylated ERK 1/2 were determined as we described previously (33) (34) (35) . To ensure equal protein loading, the same membranes were treated with stripping buffer (Pierce) for 20 min, blotted with 5% non-fat dry milk, and re-probed with a mouse anti-R-actin monoclonal antibody at 1:2000 (Sigma-Aldrich). Western blot signals were detected using enhanced chemiluminescence (Amersham) and analyzed using a microcomputer imaging device with a digital camera (MCID, Imaging Research, ONT).
Statistical Analysis
Results are expressed as mean ± SE. For measurement of intracellular Ang II levels, 6-12 samples from two separate experiments were collected for each treatment and assayed in duplicate. For Western blot data, 3 samples from two separate experiments were performed, with each treatment assayed in duplicate. Comparisons between two treatments were made by Student's unpaired t test. Comparisons between more than two treatments were made by one-way analysis of variance, followed by a Newman-Keuls test for multiple comparisons. p < 0.05 was considered significant.
RESULTS
Properties of immortalized rabbit proximal tubule cells
The morphological and electrolyte transport properties of immortalized rabbit PTCs have been reported previously (13, 27, 41) . As shown in Figure 1 , the vEPT cells grew to monolayers of cuboidal to columnar shapes (Figs. 1A and 1B) and immunofluorescence staining using specific megalin or NHE-3 antibodies shows that these cells expressed abundant megalin (Fig. 1C ) and NHE-3 proteins (Fig. 1D ).
Negative controls of megalin or NHE-3 immunofluorescence are shown in Fig. 1E and Fig. 1F , respectively. Megalin and NHE-3 are two specific proteins expressed in proximal tubule cells of the kidney, because megalin is the major endocytic receptors responsible for uptake of glomerular filtrated proteins, metals, and nutrients in the S1 segment of proximal tubules (6,8), whereas NHE-3 is the major transport proteins responsible for transcellular sodium and bicarbonate reabsorption in proximal tubules (36, 51) .
Time-dependent knockdown of AT 1 receptor expression by AT 1 R siRNA
The rationale for using AT 1 R siRNA as a tool was to knock down AT 1 receptor expression both within and on the cell membrane. Figure 2A To determine whether blockade of Ang II endocytosis by AT 1 R siRNA, losartan or colchicine affects cell surface NHE-3 proteins, an index of NHE-3 insertion into the cell membrane, we measured cell surface NHE-3 protein after biotinylation (1, 5, 14, 26, 32) . Figure 9 shows that cell surface NHE-3 proteins were also significantly reduced by AT 1 R siRNA, losartan or colchicine, suggesting that blocking endocytosis of extracellular Ang II not only reduced NHE-3 protein synthesis but also decreased NHE-3 insertion into the cell membrane. Figure 10 shows that incubation of PTCs with Ang II (1 nM) for 60 min at 37°C increased phosphorylated ERK1/2 by 60 ± 5% whereas total ERK1/2 was not affected. Pretreating PTCs with AT 1 R siRNA, losartan or colchicine before exposing them to Ang II (1 nM) all effectively blocked Ang II-induced activation of ERK1/2, suggesting that Ang II activation of ERK1/2 in PTCs may partly mediate Ang II-increased NHE-3 abundance in cell lysates as well as in apical membranes.
Discussion
We have recently shown that extracellular Ang II (Val (Fig. 3) . We found that AT 1 R siRNA markedly reduced FITC-Ang II staining in live PTCs. Second, Western blot showed that AT 1 R siRNA effectively knocked down AT 1 receptor protein abundance in a timedependent manner with a peak inhibition at 48 h after transfection (>76%) (Fig. 2) .
Third, the specificity of the AT 1 R siRNA was further confirmed in HEK 293 cells stably expressing AT 1a receptors (Fig. 3) . This level of efficiency in knocking down AT 1 receptor proteins by AT 1 R siRNA is consistent with previous reports of Vazquez et al (50) and Chen et al (9). In those studies, transfection of CHO cells with a dsRNA AT 1 R decreased AT 1a receptor expression by 80% (50), whereas in vivo transfection of mice with an Ad-AT 1a -shRNA reduced AT 1 receptors by 70% in the subfornical organ of the brain (9). AT 1a R knockdown completely blocked Ang II-stimulated calcium uptake in CHO cells (50) or decreased blood pressure when microinjected into the NTS (9). Yet there was no study that has specifically used AT 1 or AT 1a receptor-specific siRNAs to study receptor-mediated Ang II endocytosis in proximal tubule cells.
In the present study, exposure of immortalized rabbit PTCs to extracellular Ang II increased intracellular Ang II by 67%, whereas AT 1 R siRNA blocked Ang II endocytosis and reduced Ang II to control level (Fig. 4) . As a positive control, losartan also blocked Ang II endocytosis (Fig. 4) . Since the scrambled siRNA did not knock down AT 1 receptor expression per se, nor did it block receptor-mediated Ang II endocytosis (Figs.
2 and 3), we can reasonably conclude that the effect of AT 1 R siRNA was specific for AT 1 receptors. Although both AT 1 R siRNA and losartan had similar effects, losartan exerts its effects primarily by blocking cell surface AT 1 receptors (11,37) whereas AT 1 R siRNA inhibits AT 1 receptor expression and therefore fewer receptors are available to mediate Ang II endocytosis (9,34,50,54). Therefore comparison of the effects induced by AT 1 R siRNA and losartan suggests that AT 1b receptors may play little if any role in overall AT 1 receptor-mediated Ang II endocytosis in PTCs. This is not entirely surprising, because rabbit PTCs normally do not express AT 1b receptors (3, 34, 54) , and even in the rat kidney AT 1a predominates while AT 1b accounts for only a small proportion of AT 1 receptors (11). Consistent with these early studies, we recently showed that endocytotic inhibitors that block receptor-mediated endocytosis inhibited Ang II accumulation in PTCs and these effects were associated with inhibition of both basal and forskolin-induced cAMP production (34) .
In the present study, we chose NHE-3 as a functional index of proximal tubule transport function because 65-70% of glomerular filtered sodium and bicarbonate load is reabsorbed by PTCs via actions of NHE-3 (36, 38, 42) . NHE-3 is the major isoform of sodium and hydrogen exchangers, which are expressed primarily in apical membranes of early S1 proximal tubules (1, 5, 31, 36) . Noonan et al have shown that mice with NHE-3 knockout develop severe absorptive defects in the kidney and therefore cannot reabsorb the filtered load of sodium and fluid (38) . Ang II has been shown to acutely stimulate NHE-3 activity and thus sodium flux or transport in PTCs or other epithelial cells via protein kinase-mediated intracellular signaling (14, 30, 32, 42) . The acute effects of Ang II-stimulated NHE-3 activity and sodium transport are thought to be due to activation of cell surface AT 1 receptors, but whether receptor-mediated endocytosis plays any regulatory role in NHE-3 expression in PTCs has not been investigated previously to our knowledge. In the present study, we measured the abundance of total cell lysates and cell surface NHE-3 protein levels in rabbit PTCs transfected with an AT 1 R siRNA, or treated with losartan or other endocytotic inhibitors (Figs. 6-9 ). We found that Ang II significantly increased NHE-3 protein abundance and that blockade of receptor-mediated Ang II endocytosis in PTCs by AT 1 R siRNA, losartan or colchicine was all associated with significant decreases in total (Figs. 6-8) and cell surface NHE-3 protein abundance (Fig. 9) . These results therefore suggest that receptor-mediated endocytosis of extracellular Ang II does at least play a role in Ang II-regulated proximal tubule sodium transport through its actions on total and apical membrane NHE-3 expression or insertion.
Angiotensin II-increased NHE-3 abundance and the effects of blockade of receptor-mediated Ang II endocytosis by AT 1 R siRNA, losartan, and colchicines may involve activation of MAP kinase ERK 1/2. In the present study, we found that Ang II increased phosphorylated ERK 1/2 in immortalized rabbit PTCs, which was significantly attenuated by AT 1 R siRNA, losartan and colchicine (Fig. 10) . We interpret these findings as suggesting that receptor-mediated Ang II endocytosis plays at least a partial role in activation of ERK1/2. Ang II has been shown to stimulate either Gq-coupled receptors to activate phospholipase C (PLC)/PKC signaling or Gs-coupled receptors to activate adenylate cyclase/PKA signaling (11, 13, 34, 45) . Both PLC/PKC and cAMP/PKA signaling can activate MAP kinase MEK1/2, leading to phosphorylation of ERK1/2 
